Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat TRPV1 ELISA Kit (AC2538)
Cat.#: ASET-1127
Specifications
Description Rat TRPV1 ELISA Kit allows for the in vitro quantitative determination of rat TRPV1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1350 Human Clathrin Light Chain ELISA Kit (AC2761) Quantitative inquiry ASET-1036 Mouse TIMP1 ELISA Kit (AC2447) Quantitative inquiry ASET-1615 Human SOX10 ELISA Kit (AC3026) Quantitative inquiry ASET-2395 Mouse Nrg2 ELISA Kit (AC3806) Quantitative inquiry ASET-1089 Human Profilin 1 ELISA Kit (AC2500) Quantitative inquiry ASET-1550 Human TAS2R38 ELISA Kit (AC2961) Quantitative inquiry ASET-1980 Human Serine Racemase ELISA Kit (AC3391) Quantitative inquiry ASET-2212 Goat Luteinizing Hormone ELISA Kit (AC3623) Quantitative inquiry ASET-1999 Chicken Neuropeptide Y ELISA Kit (AC3410) Quantitative inquiry ASET-1180 Human Agrin ELISA Kit (AC2591) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket